Literature DB >> 10483692

[Pharmacological and clinical effectiveness of a fixed phytogenic combination trembling poplar (Populus tremula), true goldenrod (Solidago virgaurea) and ash (Fraxinus excelsior) in mild to moderate rheumatic complaints].

C Klein-Galczinsky1.   

Abstract

Besides the well-known nonsteroidal antiinflammatory drugs (NSAID) for the treatment of rheumatic pain herbal medicine can also be applied successfully. Plants with antirheumatic efficacy include Fraxini cortex, Populi cortex/folia and Solidaginis herba. This review focuses on pharmacological and clinical efficacy of a combination of Fraxinus cortex, Populus cortex/folia and Solidago herba. Antiinflammatory and analgetic properties were shown in pharmacological tests. Clinical studies conducted in the indications of the different subtypes of rheumatic diseases such as rheumatoid arthritis or osteoarthritis pointed out a similar efficacy compared to NSAID applied in average dosages. Even the rate of adverse effects of the herbal combination was half of that registered in NSAID treated patients within the clinical studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10483692

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  3 in total

1.  Fraxin Prevents Chemically Induced Hepatotoxicity by Reducing Oxidative Stress.

Authors:  Bo Yoon Chang; Young Suk Jung; Chi-Su Yoon; Jun Seok Oh; Jae Heoi Hong; Youn-Chul Kim; Sung Yeon Kim
Journal:  Molecules       Date:  2017-04-06       Impact factor: 4.411

2.  Is natural fraxin an overlooked radical scavenger?

Authors:  Pham Cam Nam; Nguyen Minh Thong; Nguyen Thi Hoa; Duong Tuan Quang; Loc Phuoc Hoang; Adam Mechler; Quan V Vo
Journal:  RSC Adv       Date:  2021-04-15       Impact factor: 3.361

3.  Scientific Evaluation of Medicinal Plants Used for the Treatment of Cervicitis (Qorohe- Rahem) in Iranian Traditional Medicine.

Authors:  Razieh Nabimeybodi; Rahele Zareshahi; Mojgan Tansaz; Marzieh Vahid Dastjerdi; Homa Hajimehdipoor
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.